ClinicalTrials.Veeva

Menu

Cardiovascular, Renal and Metabolic Profile in Patients With Acute Myocardial Infarction (REN-ACS)

G

Grigore T. Popa University of Medicine and Pharmacy

Status

Unknown

Conditions

Renal Artery Stenosis
Hypertension, Renovascular
Myocardial Infarction

Treatments

Procedure: pulse wave velocity measurement
Procedure: coronarography
Procedure: coronary angioplasty
Procedure: body composition monitoring
Procedure: renal artery angiography

Study type

Observational

Funder types

Other

Identifiers

NCT02388139
REN-ACS

Details and patient eligibility

About

Aims

  • assessment of renal artery stenosis incidence in consecutive AMI patients included in the Romanian National Programme of Primary Percutaneous Revascularisation;
  • generating a cardio-renal-metabolic profile in patients with renal atherosclerotic disease;
  • creating a local registry (based on European CARDS percutaneous interventional registries) which also includes renal, metabolic and vascular data;
  • reporting long-term follow-up data on major cardiac adverse events (MACE) in the study group.

Full description

Gathered data:

  • descriptive general demographic data;
  • previous pathologies (ischemic heart disease, peripheral arterial disease, stroke, heart failure, previous percutaneous coronary interventions, coronary artery bypass grafting - CABG, known renal disease), cardiovascular risk factors (age, weight, height, abdominal perimeter, body mass index, smoking, sedentariness, diabetes, hypertension, dyslipidaemia);
  • routine biological data and specific non-genetic biomarkers;
  • information regarding primary PCI (less than 12 hours of ischemic symptoms): coronarographic details, type of used stent, periprocedural specific complications, final TIMI - thrombolysis in myocardial infarction - flow);
  • echocardiography at admission (LVEF);
  • metabolic data (obtained from body composition monitoring) - body water, body fat tissue;
  • renal arteries angiographic details (two independent operators evaluate stenosis based on a predefined scale);
  • renal dimensions;
  • measurement of arterial stiffness through Sphigmocore pulsed-wave-velocity (24 hrs post-procedural, 2 velocities: carotid - femoral and carotid - radial);
  • heart rate variability;
  • in-hospital and one month follow-up MACE;

Enrollment

200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • adults with AMI (<12h) diagnostic confirmed;
  • included in the Romanian National Programme of Primary Percutaneous Revascularisation (for who the Guidelines recommend primary PCI);

Exclusion criteria

  • none

Trial contacts and locations

1

Loading...

Central trial contact

Alexandru Burlacu, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems